THE RISK OF BLEEDINGS IN PATIENTS WITH ATRIAL FIBRILLATION DURING ANTICOAGULANT THERAPY

Abstract

Up to date antithrombotic medications applied in patients with atrial fibrillation are discussed. Along with traditional drugs (acetylsalicylic acid, warfarin) rivaroxaban is specially consideredin terms of efficacy and safety of alone.

Keywords

• atrial fibrillation
• antithrombotic therapy
• rivaroxaban